Testosterone Cypionate vs Enanthate: Which Is Better for TRT? (2026)

Executive Summary

Testosterone cypionate and testosterone enanthate are the two workhorses of injectable TRT — between them, they account for the vast majority of testosterone prescriptions written in the United States and internationally. If you are starting TRT or considering a switch, you have likely encountered both names and wondered whether one is meaningfully better than the other, whether they are interchangeable, and whether your provider's choice of one over the other actually matters for your results.

The short answer is that cypionate and enanthate are very similar: both are esterified forms of testosterone dissolved in oil, both are administered by intramuscular injection (and increasingly by subcutaneous injection), and both produce equivalent testosterone levels when dosed appropriately. The longer answer is that the differences — in half-life, carrier oil, injection experience, availability, cost, and the 2026 supply picture — can matter for specific patients in specific circumstances. Understanding those differences helps you have a better conversation with your prescriber and advocate for the formulation that fits your protocol.

This guide covers the pharmacokinetic differences between testosterone cypionate and enanthate, how carrier oil affects injection experience, the 2026 availability and shortage situation, cost comparisons across commercial and compounded options, which online TRT clinics use which formulation, and when it actually matters which one you are on. For the broader injectable TRT context, see how to self-inject testosterone at home and testosterone cream vs injections vs pellets.

At-a-Glance Comparison

Head-to-head comparison of testosterone cypionate and testosterone enanthate. Both are esterified injectable testosterone formulations with overlapping clinical profiles. The differences are real but modest — for most men on TRT, the formulations are functionally interchangeable when dosed appropriately. Updated March 2026.

What Are Testosterone Cypionate and Enanthate? The Ester Difference

Before comparing the two formulations, it helps to understand why esters exist in the first place — because the ester is the only structural difference between them, and it determines everything else: how long the testosterone stays in your system, how it is released, and how often you need to inject. Buyers searching for testosterone cypionate vs enanthate usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Testosterone in its base (unmodified) form has a very short half-life in the body — roughly 10 minutes in circulation. That is far too short for practical TRT: you would need constant infusion to maintain stable levels. To solve this, pharmaceutical chemists attach an ester chain to the testosterone molecule at the 17-beta hydroxyl position. The ester makes the molecule more lipophilic (fat-soluble), which means it dissolves easily in oil and forms a depot in the muscle or subcutaneous tissue after injection. From that depot, the esterified testosterone slowly diffuses into the bloodstream, where esterase enzymes cleave off the ester chain and release free, bioactive testosterone. The longer the ester chain, the more lipophilic the compound, the more slowly it diffuses from the depot, and the longer the resulting half-life. Testosterone cypionate has a cyclopentylpropionate ester — an 8-carbon chain. This gives it a half-life of approximately 8 days (with published ranges of 6–10 days depending on the study, injection site, individual metabolism, and body composition). Testosterone enanthate has a heptanoate ester — a 7-carbon chain. One carbon shorter than cypionate's ester. This gives it a half-life of approximately 5–7 days (published ranges 4.5–8 days). Once the ester is cleaved, the resulting testosterone is identical. The body does not know or care whether the testosterone it is using originated from cypionate or enanthate — the active hormone is the same. The difference is entirely in the release profile from the injection depot. In practical terms: if you are on a well-managed twice-weekly injection schedule, the half-life difference between cypionate and enanthate is clinically insignificant — the dosing frequency keeps levels smooth regardless. On a once-weekly schedule, cypionate's slightly longer tail means marginally higher trough levels on day 7 compared to enanthate, but the difference is small enough that most men cannot perceive it. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: The most common misconception is that cypionate and enanthate produce different hormonal effects or that one is 'stronger' than the other. This is false. Milligram for milligram (adjusting for the slight difference in testosterone content per mg of ester — cypionate delivers about 69.90 mg of free testosterone per 100 mg, enanthate delivers about 72.03 mg per 100 mg), they produce equivalent serum testosterone levels. Any perceived difference in how they 'feel' is almost certainly attributable to carrier oil, injection technique, PIP, or placebo. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Carrier Oil and Injection Experience: Why It Matters More Than You Think

The carrier oil is often dismissed as a minor detail, but it is actually the difference that most affects your day-to-day injection experience — particularly post-injection pain (PIP), drawing speed, and allergen risk. For men who inject 100+ times per year, the injection experience compounds. Buyers searching for testosterone cypionate vs enanthate usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Commercial testosterone cypionate is typically suspended in cottonseed oil. Commercial testosterone enanthate (Delatestryl, the original branded product) is suspended in sesame oil. These are not the same experience. Cottonseed oil is thinner (lower viscosity) than sesame oil. This means: faster drawing through the needle (less time spent pulling the plunger on thick oil), smoother injection with less resistance, and generally less PIP in the first 24–48 hours. Most men who have used both formulations report that cypionate in cottonseed oil is noticeably easier to inject. Sesame oil is thicker and has a higher viscosity at room temperature. This increases draw time, requires more injection pressure, and can contribute to higher PIP, particularly in cooler environments. If you are on enanthate in sesame oil and experiencing significant PIP, warming the syringe before injection (60–90 seconds in warm water) reduces viscosity meaningfully — see the full technique in how to self-inject testosterone. Compounded formulations break the carrier-oil association entirely. Compounding pharmacies can prepare either cypionate or enanthate in MCT oil (medium-chain triglyceride — very thin, low PIP, derived from coconut or palm oil), grapeseed oil, or other bases. Some men who have PIP issues with commercial formulations find that switching to a compounded version in MCT oil resolves the problem entirely, regardless of whether they are on cypionate or enanthate. Allergen considerations: Cottonseed allergy is rare but real. Sesame allergy has been increasing in prevalence and became a legally recognized major food allergen in the US under the FASTER Act of 2021. If you have a known allergy to either oil, you must use the other formulation or a compounded version in a different carrier. Always inform your prescriber of any known allergies — this is one situation where the formulation choice is not optional. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Switching carrier oils (e.g., from commercial cypionate in cottonseed to compounded cypionate in MCT) can change your PIP experience dramatically — usually for the better. But it can also change the absorption rate slightly, which means your serum levels on the same dose may shift. If you switch carrier oils, get follow-up labs at 6–8 weeks to confirm your levels are still in target range. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

The 2026 Cypionate Shortage: What It Means and What to Do

Since early 2023, testosterone cypionate has been on the ASHP (American Society of Health-System Pharmacists) drug shortage list. This has been one of the most disruptive supply-chain events in TRT history, affecting both retail pharmacy patients and online TRT clinic patients. Understanding the current state of the shortage matters for anyone on injectable TRT in 2026. Buyers searching for testosterone cypionate vs enanthate usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

As of early 2026, the testosterone cypionate shortage remains classified as ongoing by ASHP. The situation has improved compared to 2023–2024, when many patients experienced multi-week gaps in availability, but supply is still described as intermittent. Key facts about the current shortage: The 200 mg/mL concentration is generally more available than 100 mg/mL. If you are on 100 mg/mL and experiencing availability issues, ask your provider about switching to 200 mg/mL and adjusting your injection volume accordingly. Multiple generic manufacturers are active — Hikma, Sun Pharma, Teva, and Pfizer all produce testosterone cypionate generics, but none have guaranteed consistent supply at all distribution points. Compounding pharmacies have been relatively insulated from the shortage because they source raw testosterone cypionate powder and compound their own vials, rather than depending on finished-product supply chains. Many online TRT clinics — including Defy Medical, Marek Health, and others — route prescriptions through compounding pharmacies for exactly this reason. Testosterone enanthate is an alternative that has not experienced the same shortage pressure. While less commonly prescribed in the US, it is pharmacologically equivalent and can be substituted 1:1 on a milligram basis (with the minor adjustment for ester weight difference, which most clinicians simply absorb into standard dosing). Some patients have been switched from cypionate to enanthate during shortage windows and transitioned back when supply stabilized. What to do if your cypionate supply is disrupted: (1) Ask your prescriber about switching to enanthate — either commercial (Xyosted for SubQ, or compounded for IM) or compounded enanthate in your preferred carrier oil. (2) If you are using a retail pharmacy, check alternative pharmacies — supply is often location-dependent. (3) If you are using an online TRT clinic that partners with a compounding pharmacy, supply disruption should be minimal — compounders have maintained more consistent access. (4) Do not stockpile. Ordering extra vials contributes to the supply-demand imbalance and makes the shortage worse for other patients. For more on managing the cost implications of supply disruptions, see how much TRT costs in 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: The biggest risk from the shortage is treatment gaps — men whose refill is delayed and who go days or weeks without their injection. A treatment gap produces the same hormonal decline you experienced before starting TRT: fatigue, mood instability, libido loss, and cognitive fog. If your supply is disrupted, contact your prescriber immediately rather than waiting and hoping — proactive communication almost always resolves supply issues faster. For guidance on switching providers entirely if your current clinic cannot maintain supply, see how to switch TRT providers without a gap. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Cost Comparison: Commercial vs Compounded in 2026

Cost is one of the areas where cypionate and enanthate diverge more meaningfully — not because the hormones themselves cost different amounts, but because the commercial product landscape and insurance coverage differ between them. Buyers searching for testosterone cypionate vs enanthate usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Testosterone cypionate — commercial generics: Multiple FDA-approved generics are available from manufacturers including Hikma, Sun Pharma, Teva, and Pfizer. With a GoodRx or SingleCare discount card, a 10 mL vial of testosterone cypionate 200 mg/mL costs approximately $30–80 at most retail pharmacies (Costco, Walmart, CVS, Walgreens). This is by far the cheapest option for injectable TRT when supply is available. Brand-name Depo-Testosterone is significantly more expensive ($200+) and offers no clinical advantage over generics. Insurance typically covers generic testosterone cypionate with prior authorization for a documented hypogonadism diagnosis. Testosterone enanthate — commercial: The primary commercial enanthate product in the US is Xyosted, a subcutaneous auto-injector that comes in pre-filled single-use doses (50, 75, or 100 mg). Xyosted is convenient — no vial, no syringe, no needle gauge decisions — but it costs approximately $400–600 per month without insurance. Some insurance plans cover it; others do not. For men who want the convenience of an auto-injector and are willing to pay or have coverage, Xyosted is a legitimate option. For men paying out of pocket, it is dramatically more expensive than compounded alternatives. Generic testosterone enanthate in multi-dose vials (like the Delatestryl equivalent) is less commonly stocked at US retail pharmacies, though it can be ordered. Compounded (either formulation): Compounding pharmacies prepare both cypionate and enanthate at similar price points: typically $40–120 per 10 mL vial depending on concentration, carrier oil, and pharmacy. Most online TRT clinics include medication cost in their monthly subscription ($100–200/month including consultations, labs, and medication). Compounded testosterone offers the advantage of carrier oil customization (MCT, grapeseed, etc.), concentration flexibility, and better availability during the cypionate shortage. Bottom line: If you are cost-optimizing and have access to commercial generic cypionate through a retail pharmacy, that is the cheapest path ($30–80/vial). If you are using an online TRT clinic with a compounding pharmacy partnership, cypionate and enanthate cost the same. If you specifically want the Xyosted auto-injector convenience, expect to pay significantly more. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Insurance coverage for testosterone varies dramatically by plan. Some plans cover generic cypionate with a simple prior auth; others require extensive documentation or deny coverage entirely. If your plan does not cover testosterone, the compounding pharmacy + discount card route is almost always more affordable than brand-name commercial products. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Which Online TRT Clinics Use Cypionate vs Enanthate?

Most online TRT platforms default to testosterone cypionate because it is the dominant US formulation and what most patients expect. But the clinic's pharmacy partnership and protocol philosophy determine what you actually receive — and some clinics now offer both or can switch between them based on supply and patient preference. Buyers searching for testosterone cypionate vs enanthate usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Here is the general landscape of formulation use among major online TRT platforms in 2026: Clinics that primarily prescribe cypionate: Most consumer-facing platforms — including Hims (for their injectable offering), Roman/Ro, TRT Nation, and Peter Uncaged MD — default to testosterone cypionate in their standard protocols. This reflects US prescribing convention and pharmacy stocking patterns. Clinics with compounding pharmacy partnerships: Defy Medical, Marek Health, and similar clinician-led platforms typically route prescriptions through compounding pharmacies (Empower Pharmacy, Hallandale Compounding, etc.), which can prepare either cypionate or enanthate in the patient's preferred carrier oil. These clinics are more flexible about formulation switches and more insulated from the cypionate shortage because compounders source raw API (active pharmaceutical ingredient) rather than finished products. Clinics that offer SubQ enanthate: Some specialized clinics now offer subcutaneous testosterone enanthate protocols using insulin syringes, as an alternative to traditional IM injection. Xyosted (the FDA-approved SubQ auto-injector) is less commonly prescribed through online platforms due to its high cost, but compounded SubQ enanthate is growing in popularity. The research base for SubQ enanthate is strong — a 52-week study published in the Journal of Urology demonstrated that weekly subcutaneous testosterone enanthate (50–100 mg via auto-injector) restored serum testosterone to normal range in hypogonadal men with favorable safety data. A comparative study from the Journal of Sexual Medicine found that SubQ enanthate was associated with lower post-therapy hematocrit and estradiol levels compared to IM cypionate after adjusting for covariates — potentially relevant for men who struggle with elevated HCT or E2 on standard IM protocols. Practical recommendation: If your current clinic prescribes cypionate and you are happy with your protocol, there is no reason to switch. If you experience supply disruption, significant PIP with the current carrier oil, or elevated HCT/E2 that you want to address through route optimization, ask your provider about enanthate (IM or SubQ) as an alternative. For a full provider comparison, see best online TRT clinics 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Switching formulations is not a major medical event — it is a pharmacy-level change. But any switch should include follow-up labs at 6–8 weeks to confirm your serum testosterone, estradiol, and hematocrit are still in target range. Do not assume that the same dose of enanthate will produce exactly the same levels as the same dose of cypionate, even though they are very close. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

When the Choice Actually Matters: Decision Framework

For the majority of men on TRT, testosterone cypionate and enanthate are interchangeable. But there are specific clinical scenarios where the choice matters more than usual — and knowing these helps you make the right call with your provider rather than defaulting to whatever is most convenient. Buyers searching for testosterone cypionate vs enanthate usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Use this decision framework: Default to cypionate if: You are in the US and starting TRT for the first time (it is the standard, most prescribed, and cheapest commercial generic). You prefer a thinner carrier oil for easier injection. Your pharmacy stocks it reliably. You have no sesame oil allergy (irrelevant for cypionate in cottonseed). Consider enanthate if: Cypionate is unavailable at your pharmacy due to the ongoing shortage. You have a cottonseed allergy (use enanthate in sesame or compounded in MCT). You are interested in subcutaneous injection — Xyosted is FDA-approved for SubQ delivery, and compounded SubQ enanthate protocols are well-studied. Your hematocrit or estradiol runs high on IM cypionate and your provider wants to try SubQ enanthate as a route-based optimization before adjusting dose or adding anastrozole (see anastrozole on TRT). It genuinely does not matter if: You are on a stable twice-weekly injection schedule and your labs are in range. You are using a compounding pharmacy that can prepare either formulation in the same carrier oil. You have no oil allergies and no supply issues. Your HCT and E2 are well-managed. In this case, pick whichever is more affordable and available, and do not overthink it. The active hormone is identical. The one scenario that definitely warrants a switch: If you are currently on IM cypionate, have elevated hematocrit (HCT consistently >52–54%), and your provider is considering phlebotomy or dose reduction, ask about trying SubQ enanthate first. The Pastuszak et al. comparative data showed lower post-therapy HCT with SubQ enanthate versus IM cypionate. This may allow you to maintain your dose and therapeutic levels while reducing the HCT elevation that is the most common reason men are told to reduce their TRT dose or donate blood. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Do not switch formulations, carrier oils, and injection routes simultaneously. If you change everything at once and your labs shift, you will not know which variable caused the change. Change one thing at a time, re-test at 6–8 weeks, and iterate. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

Looking for a TRT provider that can prescribe the right formulation for your needs? Use our comparison tool to evaluate clinics on protocol flexibility, compounding pharmacy access, and cost transparency.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

Is testosterone cypionate or enanthate better for TRT?

Neither is objectively better. They are the same hormone (testosterone) with slightly different ester chains. Cypionate has a marginally longer half-life (~8 days vs ~5–7 days) and uses a thinner carrier oil (cottonseed vs sesame), which makes it slightly easier to inject. Enanthate is pharmacologically equivalent. For most men, the choice comes down to availability, cost, and carrier oil preference — not hormonal differences.

What is the half-life difference between cypionate and enanthate?

Testosterone cypionate has a half-life of approximately 8 days (range 6–10). Testosterone enanthate has a half-life of approximately 5–7 days (range 4.5–8). The difference comes from cypionate having one additional carbon in its ester chain, making it slightly more lipophilic and slower to release from the injection depot. On twice-weekly injection schedules, this difference is clinically insignificant.

Can I switch from cypionate to enanthate?

Yes. Switching between cypionate and enanthate is a straightforward pharmacy-level change, not a major medical transition. Your provider can write a new prescription for the equivalent dose of the other formulation. Get follow-up labs at 6–8 weeks after switching to confirm your serum testosterone, estradiol, and hematocrit are stable.

Is there a testosterone cypionate shortage in 2026?

Yes. Testosterone cypionate has been on the ASHP drug shortage list since early 2023 and supply remains intermittent as of early 2026. The 200 mg/mL concentration is generally more available than 100 mg/mL. Compounding pharmacies have maintained better supply than retail chains. Testosterone enanthate is a suitable substitute if cypionate is unavailable.

Which is cheaper — testosterone cypionate or enanthate?

Commercial generic testosterone cypionate is typically the cheapest injectable TRT option: $30–80 per 10 mL vial with a discount card at retail pharmacies. Compounded cypionate and enanthate cost about the same ($40–120/vial). Xyosted (the branded SubQ enanthate auto-injector) is significantly more expensive at $400–600/month without insurance.

Does the carrier oil affect how testosterone works?

The carrier oil does not change the hormone itself, but it affects your injection experience. Cottonseed oil (standard in commercial cypionate) is thinner and generally easier to inject with less PIP. Sesame oil (standard in commercial enanthate) is thicker and may cause more PIP. Carrier oil can also slightly affect absorption rate, so if you switch oils, get follow-up labs to confirm stable levels.

Can I inject testosterone enanthate subcutaneously?

Yes. Xyosted is an FDA-approved subcutaneous testosterone enanthate auto-injector. Compounded testosterone enanthate can also be injected subcutaneously using insulin syringes. Research shows SubQ enanthate produces steady serum testosterone with smaller peak-to-trough fluctuations than IM injection, and may result in lower hematocrit and estradiol elevations.

Do online TRT clinics prescribe cypionate or enanthate?

Most US online TRT clinics default to testosterone cypionate. Clinics with compounding pharmacy partnerships (Defy Medical, Marek Health, etc.) can prescribe either formulation in custom carrier oils and are more flexible about switching. Some clinics now offer SubQ enanthate protocols for patients who want an alternative to traditional IM injection.

Is testosterone enanthate better for men with high hematocrit?

Possibly, when administered subcutaneously. A comparative study from the Journal of Sexual Medicine found that SubQ testosterone enanthate was associated with lower post-therapy hematocrit compared to IM testosterone cypionate. If elevated HCT is a concern on your current protocol, switching from IM cypionate to SubQ enanthate may help — discuss with your provider before reducing your dose.

What if I am allergic to cottonseed oil or sesame oil?

If you have a cottonseed allergy, use enanthate (in sesame oil) or a compounded formulation in MCT or grapeseed oil. If you have a sesame allergy, use cypionate (in cottonseed oil) or a compounded formulation in MCT oil. Sesame is a legally recognized major food allergen in the US under the FASTER Act of 2021. Always inform your prescriber of any known allergies.